← FDA Drug Approvals (Drugs@FDA)
NAPROXEN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2023-05-31
Drug application
- FDA Application #
ANDA216908- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NAPROXEN
- Generic name
- NAPROXEN
- Active ingredients
- NAPROXEN
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TP ANDA HOLDINGS
- Manufacturer
- TruPharma LLC
- First approval
- 2023-05-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown